Generium is the leading biopharmaceutical company in Russia and CIS countries. Generium develops and produces biotechnological products for rare diseases. Generium is a full-cycle production company with its own R&D center.

Products (final dosage forms):

  • Elizaria® (eculizumab) 
  • Glurazyme® (imiglucerase)
  • Tigerase® (dornase alfa)
  • Genolair® (omalizumab)
  • Coagil VII® (recombinant blood coagulation factor VIIa)
  • Octofactor® (recombinant blood coagulation factor VIII)
  • Revelise® (alteplase, tPA)

  • RU
  • 2019
    On CPHI since
Contact info
  • 273 Zavodskaya Street, Volginsky Settlement, Petushinskiy district, 601125 , Vladimir region , Russian Federation

Products from GENERIUM (3)